2023 update on European Atherosclerosis Society consensus statement on homozygous familial hypercholesterolaemia: new treatments and clinical guidance
This 2023 statement updates clinical guidance for homozygous familial
hypercholesterolaemia (HoFH), explains the genetic complexity, and provides pragmatic …
hypercholesterolaemia (HoFH), explains the genetic complexity, and provides pragmatic …
International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia
This contemporary, international, evidence-informed guidance aims to achieve the greatest
good for the greatest number of people with familial hypercholesterolaemia (FH) across …
good for the greatest number of people with familial hypercholesterolaemia (FH) across …
[HTML][HTML] World heart federation cholesterol roadmap 2022
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial
infarction, stroke and peripheral arterial disease continue to be major causes of premature …
infarction, stroke and peripheral arterial disease continue to be major causes of premature …
Familial hypercholesterolemia: global burden and approaches
L Tokgozoglu, M Kayikcioglu - Current cardiology reports, 2021 - Springer
Abstract Purpose of Review Familial hypercholesterolemia (FH) is the most common genetic
metabolic disorder characterized by markedly elevated LDL-C levels from birth leading to …
metabolic disorder characterized by markedly elevated LDL-C levels from birth leading to …
[HTML][HTML] The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet (HFD)-induced hyperlipidemia and stimulates liver LDLR expression
YN Yang, QC Wang, W Xu, J Yu, H Zhang… - Biomedicine & …, 2022 - Elsevier
Berberine (BBR) is an effective cholesterol-lowering drug. Although gut microbiota has been
implicated in the pharmacological activities of BBR, little evidence exists on the specific …
implicated in the pharmacological activities of BBR, little evidence exists on the specific …
Towards an SI-traceable reference measurement system for seven serum apolipoproteins using bottom-up quantitative proteomics: conceptual approach enabled by …
CM Cobbaert, H Althaus, I Begcevic Brkovic… - Clinical …, 2021 - academic.oup.com
Current dyslipidemia management in patients with atherosclerotic cardiovascular disease
(ASCVD) is based on traditional serum lipids. Yet, there is some indication from basic …
(ASCVD) is based on traditional serum lipids. Yet, there is some indication from basic …
Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations
SS Gidding, A Wiegman, U Groselj… - European journal of …, 2022 - academic.oup.com
Familial hypercholesterolaemia (FH) is under-recognized and under-treated in Europe
leading to significantly higher risk for premature heart disease in those affected. As treatment …
leading to significantly higher risk for premature heart disease in those affected. As treatment …
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
AJ Vallejo-Vaz, CAT Stevens, ARM Lyons… - The Lancet, 2021 - thelancet.com
Summary Background The European Atherosclerosis Society Familial
Hypercholesterolaemia Studies Collaboration (FHSC) global registry provides a platform for …
Hypercholesterolaemia Studies Collaboration (FHSC) global registry provides a platform for …
[HTML][HTML] Recent advances in the management and implementation of care for familial hypercholesterolaemia
Familial hypercholesterolaemia (FH) is a common autosomal semi-dominant and highly
penetrant disorder of the low-density lipoprotein (LDL) receptor pathway, characterised by …
penetrant disorder of the low-density lipoprotein (LDL) receptor pathway, characterised by …
New therapies for primary hyperlipidemia
CA Aguilar-Salinas, RA Gómez-Díaz… - The Journal of Clinical …, 2022 - academic.oup.com
Primary hyperlipidemias include a heterogeneous set of monogenic and polygenic
conditions characterized by a strong family aggregation, severe forms of …
conditions characterized by a strong family aggregation, severe forms of …